Literature DB >> 17179966

Osteopontin-induced survival of T cells.

Ingunn M Stromnes, Joan M Goverman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17179966     DOI: 10.1038/ni0107-19

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  13 in total

Review 1.  A molecular trio in relapse and remission in multiple sclerosis.

Authors:  Lawrence Steinman
Journal:  Nat Rev Immunol       Date:  2009-06       Impact factor: 53.106

2.  Osteopontin is a tumor autoantigen in prostate cancer patients.

Authors:  Tatiana M Tilli; Eloísio A Silva; Lívia C Matos; Douglas V Faget; Bianca F P Dias; Juliana S P Vasconcelos; Yasuyuki Yokosaki; Etel R P Gimba
Journal:  Oncol Lett       Date:  2010-11-23       Impact factor: 2.967

3.  Obesity accelerates T cell senescence in murine visceral adipose tissue.

Authors:  Kohsuke Shirakawa; Xiaoxiang Yan; Ken Shinmura; Jin Endo; Masaharu Kataoka; Yoshinori Katsumata; Tsunehisa Yamamoto; Atsushi Anzai; Sarasa Isobe; Naohiro Yoshida; Hiroshi Itoh; Ichiro Manabe; Miho Sekai; Yoko Hamazaki; Keiichi Fukuda; Nagahiro Minato; Motoaki Sano
Journal:  J Clin Invest       Date:  2016-11-07       Impact factor: 14.808

4.  Cleavage of osteopontin by matrix metalloproteinase-12 modulates experimental autoimmune encephalomyelitis disease in C57BL/6 mice.

Authors:  Angelika Goncalves DaSilva; Lucy Liaw; V Wee Yong
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

5.  Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity.

Authors:  Ekkehart Lausch; Andreas Janecke; Matthias Bros; Stefanie Trojandt; Yasemin Alanay; Corinne De Laet; Christian A Hübner; Peter Meinecke; Gen Nishimura; Mari Matsuo; Yoshiko Hirano; Sylvie Tenoutasse; Andrea Kiss; Rafael Fabiano Machado Rosa; Sharon L Unger; Raffaele Renella; Luisa Bonafé; Jürgen Spranger; Sheila Unger; Bernhard Zabel; Andrea Superti-Furga
Journal:  Nat Genet       Date:  2011-01-09       Impact factor: 38.330

6.  Genetic deficiency of Irgm1 (LRG-47) suppresses induction of experimental autoimmune encephalomyelitis by promoting apoptosis of activated CD4+ T cells.

Authors:  Hongwei Xu; Zhi-Ying Wu; Fang Fang; Lan Guo; Doris Chen; John Xi Chen; David Stern; Gregory A Taylor; Hong Jiang; Shirley ShiDu Yan
Journal:  FASEB J       Date:  2010-01-07       Impact factor: 5.191

7.  Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4+ T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis.

Authors:  Gopal Murugaiyan; Akanksha Mittal; Howard L Weiner
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

Review 8.  The Emerging Role of Immunotherapy in Intrahepatic Cholangiocarcinoma.

Authors:  Oraianthi Fiste; Ioannis Ntanasis-Stathopoulos; Maria Gavriatopoulou; Michalis Liontos; Konstantinos Koutsoukos; Meletios Athanasios Dimopoulos; Flora Zagouri
Journal:  Vaccines (Basel)       Date:  2021-04-22

Review 9.  The Tumor Microenvironment in Cholangiocarcinoma Progression.

Authors:  Luca Fabris; Keisaku Sato; Gianfranco Alpini; Mario Strazzabosco
Journal:  Hepatology       Date:  2020-11-06       Impact factor: 17.298

10.  Osteoporosis increases subsequent risk of gallstone: a nationwide population-based cohort study in Taiwan.

Authors:  Sukhontip Klahan; Chun-Nan Kuo; Shu-Chen Chien; Yea-Wen Lin; Chun-Yi Lin; Chia-Hsien Lin; Wei-Chiao Chang; Ching-I Lin; Kuo-Sheng Hung; Wei-Pin Chang
Journal:  BMC Gastroenterol       Date:  2014-11-18       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.